ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,930.85
      1.09%
      US Tech 100
      20,836.00
      1.31%
      Dow Jones
      42,840.26
      1.18%
      Brent Oil
      72.925
      0.29%
      Bitcoin
      94,724.63
      -0.40%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Maravai LifeSciences Holdings Inc (MRVI)

      7. Maravai LifeSciences Holdings Inc (MRVI) News

      Maravai LifeSciences Holdings Inc

      Maravai LifeSciences Holdings Inc (MRVI)

      NASDAQ
      5.37
      -0.06
      (-1.10%)
      Closed December 23 4:00PM
      Delayed by 15 minutes
      5.63
      0.26
      (4.84%)
      After Hours: 6:03PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      MRVI News

      Official News Only

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 18 2024
      MRVI (-1.10%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 05 2024
      MRVI (-1.10%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 18 2024
      MRVI (-1.10%)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
      Edgar (US Regulatory)
      November 13 2024
      MRVI (-1.10%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 12 2024
      MRVI (-1.10%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 12 2024
      MRVI (-1.10%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 12 2024
      MRVI (-1.10%)

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors
      Edgar (US Regulatory)
      November 08 2024
      MRVI (-1.10%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 07 2024
      MRVI (-1.10%)

      MRVI Discussion

      View Posts
      Monksdream Monksdream 10 months ago
      MRVI No 2 on the Barchart 100
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0
      Monksdream Monksdream 10 months ago
      Early Barchart 100
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
      7:24 am ET March 3, 2021 (MarketWatch)
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

      Mar 3, 2021 7:35a ETBenzinga Stock Analysis
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
      👍️0

      Your Recent History

      NASDAQ
      MRVI
      Maravai LifeSciences
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads